Bullish indicating open at $55-$60, IPO prices at $37
Blair Anthony K, the Chief Operating Officer of Zomedica Corp. (AMEX:ZOM), has recently acquired a significant number of shares in the company. According to a filing with the Securities and Exchange Commission, Blair purchased 500,000 shares of Zomedica common stock on March 17, 2025, at a price of $0.06 per share. This transaction amounted to a total value of $30,000. The purchase comes at an interesting time, as InvestingPro analysis indicates the stock is currently trading in oversold territory, with the company maintaining a strong balance sheet featuring more cash than debt.
Following this acquisition, Blair’s direct ownership of Zomedica shares increased to 900,000 shares. This move reflects continued insider interest in the company’s stock as Zomedica navigates its business activities in the pharmaceutical preparations sector. According to InvestingPro data, while the company’s stock has shown high price volatility, its financial health score remains fair, with liquid assets exceeding short-term obligations. Discover more insights about ZOM and 1,400+ other stocks through comprehensive Pro Research Reports, available exclusively with an InvestingPro subscription.
In other recent news, Zomedica Pharmaceuticals (NYSE:ZOM) Corp reported its fourth-quarter 2024 earnings with a revenue of $7.9 million, marking an 8% increase from the previous year. Despite a net loss of $7.2 million, the company maintained strong gross margins and a robust cash position of $71.4 million. The full-year revenue for 2024 reached a record $27.3 million. Zomedica’s strategic focus on expanding its presence in the veterinary and equine markets has been a contributing factor to this growth. The company plans to continue its expansion into international territories and aims to achieve cash flow breakeven at a $50 million run rate. Additionally, Zomedica has transitioned to the OTCQB Venture Market following a delisting from the NYSE American Exchange. The company is actively exploring options to enhance its share price and plans to engage investors through monthly webinars.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.